Stimulation of proliferation and migration of mouse macrophages by type B CpG-ODNs is F-spondin and IL-1Ra dependent

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Chen, Tai An ^a   Liao, Chiao Chun ^b   Cheng, Yung Chih ^a   Chen, Yen Po ^a   Hsu, Yi Fan ^a   Liang, Chi Ming ^b   Liang, Shu Mei ^a,b  

^a AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CPG B OLIGODEOXYNUCLEOTIDE; CPG OLIGODEOXYNUCLEOTIDE; F SPONDIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN P27; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; CPG-OLIGONUCLEOTIDE; F-SPONDIN PROTEIN, MOUSE; OLIGODEOXYRIBONUCLEOTIDE; SCLEROPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; CYTOLOGY; DRUG EFFECTS; MACROPHAGE; METABOLISM; RAW 264.7 CELL LINE; UPREGULATION;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR MATRIX PROTEINS; GENE KNOCKDOWN TECHNIQUES; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MACROPHAGES; MICE; MICE, INBRED BALB C; MYELOID DIFFERENTIATION FACTOR 88; OLIGODEOXYRIBONUCLEOTIDES; RAW 264.7 CELLS; S PHASE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9; UP-REGULATION;

EID: 84934978108     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128926     Document Type: Article

References (34)

1. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000; 408(6813):740-745. PMID: 11130078
2. Takeshita F, Gursel I, Ishii KJ, Suzuki K, Gursel M, Klinman DM. Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9. Semin Immunol. 2004; 16(1):17-22. doi: 10.1016/j.smim.2003.10.009 PMID: 14751759
3. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002; 20:709-760. doi: 10.1146/annurev.immunol.20.100301.064842 PMID: 11861616
4. Vollmer J, Krieg AM. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Adv Drug Deliv Rev. 2009; 61(3):195-204. doi: 10.1016/j.addr.2008.12.008 PMID: 19211030
5. Lenert P, Rasmussen W, Ashman RF, Ballas ZK. Structural characterization of the inhibitory DNA motif for the type A (D)-CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cells. DNA Cell Biol. 2003; 22(10):621-631. doi: 10.1089/104454903770238094 PMID: 14611683
6. Verthelyi D, Zeuner RA. Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol. 2003; 24(10):519-522. doi: 10.1016/S1471-4906(03)00243-6 PMID: 14552833
7. Hartmann G, Battiany J, Poeck H, Wagner M, Kerkmann M, Lubenow N, et al. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur J Immunol. 2003; 33(6):1633-1641. doi: 10.1002/eji.200323813 PMID: 12778481
8. Park Y, Lee SW, Sung YC. Cutting Edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3′-OH kinase pathway. J Immunol. 2002; 168(1):5-8. PMID: 11751939
9. Sohn WJ, Lee KW, Choi SY, Chung E, Lee Y, Kim TY, et al. CpG-oligodeoxynucleotide protects immune cells from gamma-irradiation-induced cell death. Mol Immunol. 2006; 43(8):1163-1171. doi: 10.1016/j.molimm.2005.07.020 PMID: 16122803
10. Yi AK, Chang M, Peckham DW, Krieg AM, Ashman RF. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol. 1998; 160(12):5898-5906. PMID: 9637502
11. Rhee JW, Lee KW, Sohn WJ, Lee Y, Jeon OH, Kwon HJ, et al. Regulation of matrix metalloproteinase-9 gene expression and cell migration by NF-kappa B in response to CpG-oligodeoxynucleotides in RAW 264.7 cells. Mol Immunol. 2007; 44(6):1393-1400. doi: 10.1016/j.molimm.2006.05.003 PMID: 16780951
12. Burstyn-Cohen T, Frumkin A, Xu YT, Scherer SS, Klar A. Accumulation of F-spondin in injured peripheral nerve promotes the outgrowth of sensory axons. J Neurosci. 1998; 18(21):8875-8885. PMID: 9786993
13. Klar A, Baldassare M, Jessell TM. F-Spondin - a Gene Expressed at High-Levels in the Floor Plate Encodes a Secreted Protein That Promotes Neural Cell-Adhesion and Neurite Extension. Cell. 1992; 69(1):95-110. doi: 10.1016/0092-8674(92)90121-R PMID: 1555244
14. Berry E, Woo W-M, Chisholm A. Role of the Caenorhabditis elegans Extracellular Matrix Protein F-Spondin/SPON-1 in Neural Development. Available: https://cbse.soe.ucsc.edu/sites/default/files/neural-devel-berry041106.pdf
15. Burstyn-Cohen T, Tzarfaty V, Frumkin A, Feinstein Y, Stoeckli E, Klar A. F-Spondin is required for accurate pathfinding of commissural axons at the floor plate. Neuron. 1999; 23(2):233-246. PMID: 10399931
16. Cheng YC, Liang CM, Chen YP, Tsai IH, Kuo CC, Liang SM. F-spondin plays a critical role in murine neuroblastoma survival by maintaining IL-6 expression. J Neurochem. 2009; 110(3):947-955. doi: 10.1111/j.1471-4159.2009.06186.x PMID: 19549008
17. Nagarajan G, Kuo CC, Liang CM, Chen CM, Liang SM. Effects of CpG-B ODN on the protein expression profile of swine PBMC. Vet Res. 2007; 38(6):795-808. doi: 10.1051/vetres:2007032 PMID: 17727805
18. Hallegua DS, Weisman MH. Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases. Ann Rheum Dis. 2002; 61(11):960-967. PMID: 12379516
19. Dewberry RM, Crossman DC, Francis SE. Interleukin-1 receptor antagonist (IL-1RN) genotype modulates the replicative capacity of human endothelial cells. Circ Res. 2003; 92(12):1285-1287. doi: 10.1161/01.RES.0000078172.52740.9B PMID: 12764021
20. Dewberry RM, King AR, Crossman DC, Francis SE. Interleukin-1 receptor antagonist (IL-1ra) modulates endothelial cell proliferation. Febs Lett. 2008; 582(6):886-890. doi: 10.1016/j.febslet.2008.02.021 PMID: 18282478
21. Sgroi A, Gonelle-Gispert C, Morel P, Baertschiger RM, Niclauss N, Mentha G, et al. Interleukin-1 receptor antagonist modulates the early phase of liver regeneration after partial hepatectomy in mice. Plos One. 2011; 6(9):e25442. doi: 10.1371/journal.pone.0025442 PMID: 21980458
22. Liao CC, Ho MY, Liang SM, Liang CM. Recombinant protein rVP1 upregulates BECN1-independent autophagy, MAPK1/3 phosphorylation and MMP9 activity via WIPI1/WIPI2 to promote macrophage migration. Autophagy. 2013; 9(1):5-19. doi: 10.4161/Auto.22379 PMID: 23051912
23. Yasuda H, Leelahavanichkul A, Tsunoda S, Dear JW, Takahashi Y, Ito S, et al. Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am J Physiol - Renal Physiol. 2008; 294(5):F1050-F1058. doi: 10.1152/ajprenal.00461.2007
24. Abel K, Wang Y, Fritts L, Sanchez E, Chung E, Fitzgerald-Bocarsly P, et al. Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoid dendritic cells. Clin Diagn Lab Immunol. 2005; 12(5):606-621. doi: 10.1128/CDLI.12.5.606-621.2005 PMID: 15879022
25. Crabtree TD, Jin L, Raymond DP, Pelletier SJ, Houlgrave CW, Gleason TG, et al. Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge. Infect Immun. 2001; 69(4):2123-2129. doi: 10.1128/IAI.69.4.2123-2129.2001 PMID: 11254566
26. Utaisincharoen P, Anuntagool N, Chaisuriya P, Pichyangkul S, Sirisinha S. CpG ODN activates NO and iNOS production in mouse macrophage cell line (RAW 264.7). Clin Exp Immunol. 2002; 128(3):467-473. PMID: 12067301
27. Shirota H, Klinman DM. Effect of CpG ODN on monocytic myeloid derived suppressor cells. Oncoimmunology. 2012; 1(5):780-782. doi: 10.4161/onci.19731 PMID: 22934281
28. Pera T, Zuidhof AB, Smit M, Menzen MH, Klein T, Flik G, et al. Arginase inhibition prevents inflammation and remodeling in a guinea pig model of chronic obstructive pulmonary disease. J Pharmacol Exp Ther. 2014; 349(2):229-238. doi: 10.1124/jpet.113.210138 PMID: 24563530
29. Cheng YC, Chen TA, Chen CY, Liang CM, Liang SM. 3′poly-G-tailed ODNs inhibit F-spondin to induce cell death and neurite retraction in rat embryonic neurons. Mol Neurobiol. 2012; 45(3):536-549. doi: 10.1007/s12035-012-8275-8 PMID: 22592270
30. D'Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature. 1995; 374(6524):719-723. doi: 10.1038/374719a0 PMID: 7715726
31. Oka H, Mori M, Kihara H. F-spondin inhibits migration and differentiation of osteoclastic precursors. J Periodontol. 2011; 82(12):1776-1783. doi: 10.1902/jop.2011.110111 PMID: 21488757
32. Zisman S, Marom K, Avraham O, Rinsky-Halivni L, Gai U, Kligun G, et al. Proteolysis and membrane capture of F-spondin generates combinatorial guidance cues from a single molecule. J Cell Biol. 2007; 178(7):1237-1249. doi: 10.1083/jcb.200702184 PMID: 17875744
33. Dragoi AM, Fu X, Ivanov S, Zhang P, Sheng L, Wu D, et al. DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA. Embo J. 2005; 24(4):779-789. doi: 10.1038/sj.emboj.7600539 PMID: 15678105
34. Sanjuan MA, Rao N, Lai KT, Gu Y, Sun S, Fuchs A, et al. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. J Cell Biol. 2006; 172(7):1057-1068. doi: 10.1083/jcb.200508058 PMID: 16567503